PRE-LAUNCH PREVIEW Directory review is underway. Contact details are available below.
InPharm.

INDIA · EUROPE · GLOBAL OPPORTUNITIES

Good sourcing starts with
better questions.

A proposed B2B venture connecting pharmaceutical sourcing research with a clear, documented qualification process.

For Indian suppliers and prospective buyers in Europe and beyond. One defined requirement. One carefully assessed route at a time. Prepare a local, non-confidential brief, then contact Vinod Kumar Jain using your own email application.

PROJECT OVERVIEW

What is available. What comes next.

The current site supports understanding and preparation. Commercial service scope and the venture’s operating arrangements remain to be confirmed.

CURRENT

Information and preparation

Stakeholder guidance, a local brief builder and a named email contact. Email is sent only by you through your own application. No product orders or payments are accepted.

PROPOSED

Bounded sourcing support

A defined requirement, dated candidate research, open qualification questions and a handover to responsible professionals. Each service depends on competence, permissions and an agreed engagement.

NOT AVAILABLE

Private or automated services

No accounts, private identity access, dossier uploads, AI chat, automated approval, live monitoring, regulatory submission or payment handling. No launch dates are promised.

A FOCUSED START

Clarity at every step.

These are proposed service areas. Availability and scope remain subject to confirmation of the venture’s role, competence and required permissions.

01 / DISCOVERY

A relevant starting point

Frame the product category, intended market and commercial need before researching possible suppliers or counterparties.

02 / DOCUMENTATION

Evidence with context

Distinguish published information from independently assessed facts. Record the source, date, scope and questions that remain. Missing, withheld or conflicting evidence stays explicitly unresolved.

03 / COORDINATION

Clear responsibilities

Identify who needs to review each question. Quality decisions and regulatory approvals remain with the appropriately authorised professionals.

YOUR PERSPECTIVE

A clear starting point for every stakeholder.

Explore the questions and responsibilities relevant to your organisation. These pages describe potential participation, not established partnerships.

CURATED DISCOVERY

Find the right starting point.

Browse by geography and organisation role. Public records will use masked names such as A**. Inclusion will not imply partnership, endorsement, qualification or a request for offers.

0 public records

The public directory is being prepared.

No company records have been approved for publication. Research candidates remain private while their public fields are reviewed.

Geography describes scope, not permission.

India is the intended supplier-research focus; Europe and other regions are prospective buyer-research areas. A region filter does not establish market access or a local office. Country options will be drawn from reviewed public records. Headquarters and markets served must be kept distinct.

There are currently no approved public country records. Organisation scale and start-up stage are separate attributes; unsupported classifications remain unknown. No commercial demand or product availability is implied.

Masking is not anonymity. Geography and capabilities may still identify an organisation. Business scale and start-up stage will be shown as unknown unless supported by dated evidence; no size classification has yet been adopted.

FOR BUYERS

Start with the requirement.

A useful brief identifies the broad category, destination market and type of support needed. Product and dossier rights, territory restrictions, site qualification, import routes and supply arrangements require separate specialist assessment.

FOR SUPPLIERS

Start with the evidence.

Prepare your legal entity, manufacturing-site scope and relevant public evidence for a future review. Participation will not confer a verified badge or imply a commercial relationship.

PROPOSED SOURCING WORKFLOW

Move forward only when the next question is answered.

  1. Frame the need. Identify the broad category, intended country, organisation role and desired support without confidential details.
  2. Assess fit and responsibilities. Confirm whether a suitable engagement can be offered and who would own each commercial, quality and regulatory decision.
  3. Research with dated evidence. Record the exact entity and site privately, source scope and unresolved questions. Public records use only reviewed, masked fields.
  4. Arrange specialist assessment. Product and dossier rights, territory restrictions, quality qualification, importation and procurement eligibility need appropriate review.
  5. Agree any engagement separately. Scope, responsibilities, confidentiality, fees and delivery terms require explicit agreement. A message or directory entry is not project acceptance.

RESPONSIBILITY BOUNDARIES

Research is a starting point for review.

This site does not establish that a product may be offered, imported, supplied or used in a market. Actual activities and jurisdiction-specific requirements must be assessed before a project proceeds.

Different product routes

API, finished-product and investigational-product projects require separate assessment. No universal approval, dossier format or market-access pathway is asserted here.

Evidence has limits

A published statement is not an audit or inspection. Missing, withheld, conflicting and outdated evidence must remain unresolved until appropriately assessed.

Accountability stays clear

InPharm claims no broker registration, import licence, QP authority or regulatory validation capability. Any regulated activity requires the appropriate permissions and accountable parties.

CLEAR BOUNDARIES

Before you move forward.

Is InPharm a medicine marketplace?

No. This preview describes a proposed sourcing and coordination approach. It does not offer medicines for sale, accept orders or provide medical advice.

Are directory entries qualified suppliers or partners?

No. Research and published evidence do not establish qualification, availability, willingness to work together or a commercial relationship. No public records are currently approved.

What happens to information entered here?

The draft builder runs in your browser. It does not transmit or persist your draft in application storage. A downloaded draft remains on your device. The contact link opens your email application; messages you choose to send go to Vinod Kumar Jain at vinod@philojain.com through your email provider. Automated collection is disabled. Hosting may process routine connection metadata; a complete hosting and email privacy notice must be reviewed before operational launch.

Can I sign up to see company identities?

Accounts are not available. Any future access will require defined eligibility and disclosure rules; signing up alone will not unlock private research.

YOUR NEXT STEP

Prepare a clear,
non-confidential brief.

Prepare a draft on your device, then review it before contacting Vinod Kumar Jain. This tool does not send anything.

Keep patient information, prescriptions, dossiers, prices, contracts and confidential manufacturing details out of the draft.

Business contact
Vinod Kumar Jain

vinod@philojain.com ↗

This link opens your email application. Review and send the message yourself. Email goes to Vinod Kumar Jain through your email provider; this website does not submit it. Send only a minimal, non-confidential business enquiry.

Non-confidential business requirements only. No personal, patient or sensitive commercial information. Nothing is submitted.